Details for New Drug Application (NDA): 064126
✉ Email this page to a colleague
The generic ingredient in ERYTHROMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for 064126
Tradename: | ERYTHROMYCIN |
Applicant: | Padagis Us |
Ingredient: | erythromycin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 064126
Physiological Effect | Decreased Sebaceous Gland Activity |
Medical Subject Heading (MeSH) Categories for 064126
Suppliers and Packaging for NDA: 064126
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN | erythromycin | SWAB;TOPICAL | 064126 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-962 | 45802-962-72 | 60 APPLICATOR in 1 JAR (45802-962-72) / .8 mL in 1 APPLICATOR |
ERYTHROMYCIN | erythromycin | SWAB;TOPICAL | 064126 | ANDA | Bryant Ranch Prepack | 63629-8648 | 63629-8648-1 | 60 APPLICATOR in 1 JAR (63629-8648-1) / .8 mL in 1 APPLICATOR |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SWAB;TOPICAL | Strength | 2% | ||||
Approval Date: | Jul 3, 1996 | TE: | AT | RLD: | No |
Complete Access Available with Subscription